logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q3 adjusted earnings Miss Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$314 million in Q3 vs. -$273 million in the same period last year.
-EPS: -$0.29 in Q3 vs. -$0.27 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $637 million or $0.58 per share for the period.
-Analysts projected $0.59 per share
-Revenue: $4.26 billion in Q3 vs. $4.53 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.30 - $2.50
Full year revenue guidance: $17.2 - $ 17.4 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>